Oxymatrine Induces Liver Injury through JNK Signalling Pathway Mediated by TNF‐α In Vivo

By  

BASIC AND CLINICAL PHARMACOLOGY & TOXICOLOGY (ELECTRONIC), Vol. 119, Iss. 4, 2016-10 ,pp. : 405-411

John Wiley & Sons Inc

Access to resources Recommend Favorite

Infection and Malignancy Risk in Patients Treated with TNF Inhibitors for Immune-Mediated Inflammatory Diseases

By  

Current Drug Safety, Vol. 12, Iss. 3, 2017-10 ,pp. : 162-170

Bentham Science Publishers

Access to resources Recommend Favorite

Involvement of corticotropin-releasing hormone receptor subtypes 1 and 2 in peripheral opioid-mediated inhibition of inflammatory pain

By Mousa S.A.   Bopaiah C.P.   Stein C.   Schafer M.  

Pain, Vol. 106, Iss. 3, 2003-12 ,pp. : 297-307

Elsevier

Access to resources Recommend Favorite

Spondyloarthropathy in inflammatory bowel disease patients on TNF inhibitors

By  

INTERNAL MEDICINE JOURNAL, Vol. 45, Iss. 11, 2015-11 ,pp. : 1154-1160

John Wiley & Sons Inc

Access to resources Recommend Favorite

Review article: pharmacological aspects of anti‐TNF biosimilars in inflammatory bowel diseases

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 10, 2015-11 ,pp. : 1158-1169

John Wiley & Sons Inc

Access to resources Recommend Favorite